Results 291 to 300 of about 1,262,540 (308)

Renal cancer vaccine improves progression-free survival

Inpharma Weekly, 2004
openaire   +1 more source

Osimertinib improves progression-free survival in NSCLC

The Lancet Respiratory Medicine, 2017
openaire   +1 more source

Progression-free survival increased for multiple myeloma

British Journal of Hospital Medicine, 2012
openaire   +1 more source

Progression Free Survival and Overall Survival in NADIM II Study

2022
Provencio, M, Serna, R, Nadal, E, Larriba, JLG, Martinez-Marti, A, Bernabe, R, Bosch-Barrera, J, Benito, CG, Calvo, V, Insa, A, Ponce, S, Reguart, N, De Castro, J, Massuti, B, Palmero, R, de la Rosa, CA, Mosquera, J, Cobo, M, Aguilar, A, Vivanco, GL, Camps, C, Trancho, FH, Castro, RL, Moran, T, Barneto, I, Rodriguez-Abreu, D, Romero, A   +26 more
openaire   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
Jianqing Zhu, Mo Chen, Ning Li
exaly  

Young Adult Oncology: The Patients and Their Survival Challenges

Ca-A Cancer Journal for Clinicians, 2007
W Archie Bleyer
exaly  

The value of progression-free survival to patients with advanced-stage cancer

Nature Reviews Clinical Oncology, 2011
exaly  

Aiming at a Curative Strategy for Follicular Lymphoma

Ca-A Cancer Journal for Clinicians, 2008
exaly  

Valid Analysis of Brain-Specific Progression-Free Survival—Reply

JAMA Oncology
Tom Wei-Wu, Chen, Ming-Shen, Dai, Yen-Shen, Lu   +2 more
openaire   +2 more sources

NEJ026 trial: progression-free survival benefit is not enough

The Lancet Oncology, 2019
openaire   +2 more sources